Sridhar Krishnamurti, PHD in Dadeville, AL - Audiologist

Sridhar Krishnamurti, PHD is a Audiologist based in Dadeville, Alabama. Sridhar Krishnamurti is licensed to practice in Alabama (license number 788A) and his current practice location is 301 Mariarden Rd, Lake Martin Community Hospital, Dadeville, Alabama. He can be reached at his office (for appointments etc.) via phone at (256) 825-7821.

NPI number for Sridhar Krishnamurti is 1942266408 and his current mailing address is 2257 Barrington Ct, Auburn, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1942266408.

Contact Information

	Sridhar Krishnamurti, PHD
	301 Mariarden Rd, Lake Martin Community Hospital, Dadeville, AL 36853
	(256) 825-7821
	(256) 825-5742

Healthcare Provider's Profile

Full Name	Sridhar Krishnamurti
Gender	Male
Speciality	Audiologist
Location	301 Mariarden Rd, Dadeville, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1942266408
Provider Enumeration Date: 04/25/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Sridhar Krishnamurti such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942266408	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	788A (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sridhar Krishnamurti is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sridhar Krishnamurti, PHD 2257 Barrington Ct, Auburn, AL 36830-4243 Ph: (334) 844-9627	Sridhar Krishnamurti, PHD 301 Mariarden Rd, Lake Martin Community Hospital, Dadeville, AL 36853 Ph: (256) 825-7821

News Archive

Access Pharmaceuticals initiates Phase I/II dose escalating study for Thiarabine

Access Pharmaceuticals, Inc., today announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for patients with hematologic malignancies (cancers of the blood). The primary objective of the study is to determine the maximum tolerated dose (MTD) in two different dosing schedules with various leukemias and lymphomas and recommended Phase II dose. The program is being led by Hagop Kantarjian, M.D., Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Novel polygenic hazard score captures age variations of aggressive prostate cancer

An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated a genetic tool for predicting age of onset of aggressive prostate cancer, a disease that kills more than 26,000 American men annually.

Terminology, framing efforts have no effect on public opinion concerning debate on same-sex marriage

A study by Indiana University researchers found that terminology and efforts to frame an issue - often effective in influencing public opinion - have no effect on public opinion concerning the ongoing debate in the U.S. over legalizing same-sex marriage.

Patient registry yields new data that is crucial for early diagnosis and treatment of FMD

A patient registry is proving invaluable in cataloging the clinical features, symptoms, severity, and outcomes of fibromuscular dysplasia (FMD), a non-inflammatory vascular disease that can cause narrowing of arteries in the carotid (neck) and renal (kidney) arteries, which can result in headache, strokes, and aneurysms.

Sridhar Krishnamurti, PHD - Audiologist in Dadeville, AL